
The Role of Nutraceuticals in Statin Intolerant Patients
Keywords: cardiovascular risk; dyslipidemia; nutraceuticals; position paper; statin intolerance; CVD; cardiovascular disease; HDL-C; high-density lipoprotein cholesterol; HMG-CoA; hydroxymethylglutaryl coenzyme A; ILEP; International Lipid Expert Panel; LDL-C; low-